Clinical Trial Update: Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection

View source ↗

Summary

This clinical trial update discusses efforts to identify biomarkers predicting sensitivity or resistance to EGFR-TKIs in non-small cell lung cancer to guide pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Armando Santoro, MD | Conditions: NON-SMALL-CELL LUNG CANCER | Status: COMPLETED